In the liver, which of the following is responsible for the metabolism of alcohol?
Detoxification of benzoic acid is chiefly done by?
All of the following enzymes and their reactions are involved in the metabolism of xenobiotics, EXCEPT:
One of the obvious consequences of alcohol (ethanol) ingestion in many individuals is facial flushing and increased heart rate, triggered off by alcohol getting metabolized to what compound?
A 45-year-old woman has been admitted to a substance abuse center for her alcoholism. As a first attempt to curb the patient's drinking, she is given a drug that will lead to an elevation of which one of the following metabolites if she drinks alcohol?
All of the following result in detoxification of drugs except?
Glucuronyl conjugation of which amino acid leads to maximum excretion through urine?
Which of the following is metabolized like xenobiotics?
Detoxication of drugs is controlled by which enzyme system?
In chronic alcoholism, which component, excluding enzymes, is rate-limiting for alcohol metabolism?
Explanation: **Explanation:** The metabolism of alcohol (ethanol) in the liver is a multi-enzymatic process involving three distinct pathways. While **Alcohol Dehydrogenase (ADH)** is the primary pathway, the other systems play crucial roles depending on the concentration of alcohol and the chronicity of intake. 1. **Alcohol Dehydrogenase (ADH):** This is the major cytosolic enzyme responsible for converting ethanol to acetaldehyde. It follows zero-order kinetics and is the primary pathway for moderate alcohol consumption. 2. **Microsomal Ethanol-Oxidizing System (MEOS):** Located in the smooth endoplasmic reticulum, this pathway utilizes **CYP2E1**. It is induced during chronic alcohol consumption or when blood alcohol levels are high (high $K_m$ for ethanol). 3. **Aldehyde Dehydrogenase (ALDH):** This mitochondrial enzyme is responsible for the second step of metabolism, converting the toxic intermediate **acetaldehyde** into acetate. Since the question asks for the "metabolism of alcohol" (the overall process), ALDH is an integral component of this metabolic chain. **Why "All of the above" is correct:** Alcohol metabolism is not restricted to a single enzyme. It requires the coordinated action of ADH and ALDH for complete breakdown, with MEOS serving as a significant inducible alternative pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram:** Inhibits **ALDH**, leading to an accumulation of acetaldehyde, which causes the "disulfiram-like reaction" (nausea, flushing, tachycardia). * **Fomepizole:** Inhibits **ADH**; it is used as an antidote in methanol or ethylene glycol poisoning to prevent the formation of toxic metabolites. * **NADH/NAD+ Ratio:** Both ADH and ALDH reactions increase the NADH/NAD+ ratio, leading to metabolic complications like lactic acidosis, fasting hypoglycemia, and fatty liver (steatosis). * **Catalase:** A minor pathway in peroxisomes that also contributes to ethanol oxidation.
Explanation: **Explanation:** The detoxification of **benzoic acid** occurs primarily through **conjugation with glycine** to form **hippuric acid**. This process takes place in the liver and kidneys. Benzoic acid is first activated to benzoyl-CoA (using ATP and Coenzyme A), which then reacts with glycine via the enzyme *glycine N-acyltransferase*. Hippuric acid is water-soluble and easily excreted in the urine. This is a classic example of "Phase II" detoxification. **Analysis of Options:** * **Glycine (Correct):** It is the specific amino acid used for the conjugation of aromatic acids like benzoic acid and salicylic acid. * **Glucuronic acid:** While it is the most common conjugation agent for many drugs and bilirubin (forming glucuronides), it is not the *chief* pathway for benzoic acid. * **Glutamine:** This amino acid is specifically used for the detoxification of **phenylacetic acid** (forming phenylacetylglutamine), particularly in humans and primates. * **Arginine:** Arginine is not a standard conjugation agent in human detoxification pathways; it is primarily involved in the Urea Cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Hippuric Acid Test:** Historically used as a liver function test; a low output of hippuric acid after a benzoic acid load indicates hepatic impairment. * **Phenylacetic Acid:** Remember that **Glutamine** conjugates phenylacetic acid. * **Bilirubin & Steroids:** These are primarily detoxified via **Glucuronic acid**. * **Aspirin:** Salicylic acid (from aspirin) is also conjugated with glycine to form **salicyluric acid**.
Explanation: **Explanation:** The metabolism of xenobiotics (detoxification) occurs primarily in the liver through two phases. **Cytochrome oxidase** is the correct answer because it is **not** involved in detoxification; rather, it is **Complex IV of the Electron Transport Chain (ETC)** located in the inner mitochondrial membrane, responsible for reducing oxygen to water to generate ATP. **Analysis of Options:** * **Cytochrome P450 (Option B):** This is the most important component of the Phase I detoxification system. These are heme-containing monooxygenases located in the smooth endoplasmic reticulum (microsomes) that catalyze the metabolism of various drugs and toxins. * **Hydroxylation (Option D):** This is the most common reaction in **Phase I metabolism**. It involves the introduction of a hydroxyl group (-OH) into the xenobiotic, often mediated by Cytochrome P450, making the molecule more polar and providing a site for Phase II conjugation. * **Methylation (Option C):** This is a specific reaction occurring in **Phase II metabolism**. Phase II involves conjugation reactions (like glucuronidation, sulfation, and methylation) that further increase the water solubility of the metabolite to facilitate excretion via urine or bile. **High-Yield Clinical Pearls for NEET-PG:** * **Phase I Reactions:** Oxidation (most common), Reduction, and Hydrolysis. * **Phase II Reactions:** Conjugation (Glucuronidation is the most common; Glutathione conjugation is vital for neutralizing reactive metabolites like NAPQI in paracetamol toxicity). * **Inducers vs. Inhibitors:** Phenytoin and Rifampicin are classic CYP450 inducers, while Ketoconazole and Cimetidine are potent inhibitors—a frequent topic for integrated Pharmacology-Biochemistry questions.
Explanation: ### Explanation **Correct Answer: B. Acetaldehyde** **Mechanism:** Ethanol is primarily metabolized in the liver by the enzyme **Alcohol Dehydrogenase (ADH)** into **Acetaldehyde**. Acetaldehyde is a highly reactive and toxic intermediate. In many individuals, particularly those with a genetic deficiency or reduced activity of **Aldehyde Dehydrogenase (ALDH2)**, acetaldehyde accumulates in the blood. This accumulation triggers the release of histamine and catecholamines, leading to peripheral vasodilation (facial flushing), tachycardia (increased heart rate), nausea, and palpitations. This physiological reaction is commonly known as the "Alcohol Flush Reaction." **Analysis of Incorrect Options:** * **A. Formaldehyde:** This is the toxic metabolite of **Methanol**. Formaldehyde is further oxidized to formic acid, which causes optic nerve damage and metabolic acidosis. * **C & D. Propanaldehyde and Butanaldehyde:** These are aldehydes derived from propanol and butanol, respectively. They are not produced during the normal metabolic pathway of ethanol ingestion. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram (Antabuse):** This drug inhibits the enzyme **ALDH**, causing an intentional accumulation of acetaldehyde if alcohol is consumed. This produces an unpleasant "Disulfiram-like reaction," used as aversion therapy in chronic alcoholism. * **Drugs causing Disulfiram-like reactions:** Metronidazole (most common), Cefotetan, Griseofulvin, and Sulfonylureas (Tolbutamide). * **Rate-limiting step:** The conversion of ethanol to acetaldehyde by ADH is a **zero-order kinetics** process (constant amount of drug eliminated per unit time). * **Co-enzyme:** Both ADH and ALDH require **NAD+** as a co-enzyme, leading to an increased NADH/NAD+ ratio in alcoholics, which contributes to lactic acidosis and fatty liver.
Explanation: ### Explanation The correct answer is **Acetaldehyde**. **Mechanism of Action:** The drug described is **Disulfiram**, which is used as an aversion therapy for chronic alcoholism. Alcohol metabolism follows a two-step oxidative pathway: 1. **Ethanol** is converted to **Acetaldehyde** by the enzyme *Alcohol Dehydrogenase (ADH)*. 2. **Acetaldehyde** is then converted to **Acetic acid** (Acetate) by the enzyme *Aldehyde Dehydrogenase (ALDH)*. Disulfiram acts by irreversibly inhibiting **Aldehyde Dehydrogenase**. If the patient consumes alcohol while on this medication, acetaldehyde cannot be converted to acetic acid, leading to its rapid accumulation in the blood. This results in the **Disulfiram-like reaction**, characterized by flushing, tachycardia, nausea, vomiting, and hypotension, which serves as a deterrent to drinking. **Analysis of Incorrect Options:** * **A. Acetic acid:** This is the product of acetaldehyde metabolism. Since ALDH is inhibited, the levels of acetic acid will decrease, not increase. * **C. Ethanol:** While ethanol levels remain high if not metabolized, the specific "toxic" metabolite responsible for the clinical symptoms of the drug-alcohol interaction is acetaldehyde. * **D. Carbon dioxide:** This is the end product of the complete oxidation of acetate in the TCA cycle. Its levels are not acutely elevated by Disulfiram. **High-Yield Clinical Pearls for NEET-PG:** * **Disulfiram-like reaction** can also be caused by other drugs: **Metronidazole** (most common), **Sulfonylureas** (1st gen like Chlorpropamide), **Griseofulvin**, and certain **Cephalosporins** (Cefoperazone, Cefotetan). * **Fomepizole** (inhibits Alcohol Dehydrogenase) is the antidote for Methanol and Ethylene glycol poisoning. * Alcohol metabolism follows **Zero-order kinetics** (a constant amount of drug is eliminated per unit time).
Explanation: ### Explanation The detoxification of drugs and xenobiotics primarily occurs in the liver through **Phase I (Functionalization)** and **Phase II (Conjugation)** reactions. **Why Cytochrome Oxidase is the correct answer:** **Cytochrome oxidase (Complex IV)** is a key enzyme in the **Electron Transport Chain (ETC)** located in the inner mitochondrial membrane. Its primary function is to facilitate cellular respiration by transferring electrons to oxygen to form water. It is **not** involved in the metabolism or detoxification of drugs. **Analysis of Incorrect Options:** * **Cytochrome P450 (CYP450):** This is the most critical enzyme system for Phase I detoxification. These are heme-containing proteins located in the smooth endoplasmic reticulum (microsomes) that catalyze the oxidation of various hydrophobic drugs. * **NADPH Cytochrome P450 Reductase:** This enzyme is an essential component of the microsomal hydroxylating system. It transfers electrons from NADPH to the Cytochrome P450 enzyme, enabling the catalytic cycle to proceed. * **Monooxygenase:** This is a functional classification for the CYP450 system. They are called monooxygenases because they incorporate one atom of molecular oxygen into the substrate (drug) and reduce the other atom to water. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** Phase I enzymes are primarily found in the **Smooth Endoplasmic Reticulum** (Microsomal fraction), whereas Phase II enzymes are mostly in the **Cytosol** (except UDP-glucuronyltransferase). * **Inducers vs. Inhibitors:** Phenobarbital and Rifampicin are classic **CYP450 inducers**, while Ketoconazole and Grapefruit juice are potent **inhibitors**. * **Suicide Inhibition:** Cytochrome oxidase (the correct answer here) is inhibited by **Cyanide and Carbon Monoxide**, leading to cellular hypoxia.
Explanation: In biochemistry, detoxification (biotransformation) involves converting lipophilic compounds into hydrophilic metabolites for excretion. While glucuronic acid typically conjugates with drugs and bilirubin, it also conjugates with specific amino acids to facilitate their renal clearance. **Explanation of the Correct Answer:** **Alanine (Option B)** is the correct answer because, among the options provided, it forms the highest proportion of glucuronyl conjugates excreted in the urine. Glucuronidation of amino acids is a specific pathway where the glucuronic acid moiety is attached to the amino group. Research into metabolic clearance patterns indicates that alanine-glucuronide conjugates represent a significant fraction of amino acid-based detoxification products found in human urine. **Analysis of Incorrect Options:** * **Glycine (Option A):** While glycine is a major player in Phase II detoxification (e.g., conjugating with benzoic acid to form **hippuric acid**), it primarily undergoes **conjugation** as the substrate itself rather than being the primary target for glucuronidation in high volumes compared to alanine. * **Proline (Option C) and Serine (Option D):** These amino acids can undergo various metabolic transformations, but they do not form glucuronyl conjugates in quantities significant enough to match the urinary excretion levels of alanine conjugates. **NEET-PG High-Yield Pearls:** * **UDP-Glucuronosyltransferase (UGT):** The enzyme responsible for glucuronidation, located in the endoplasmic reticulum. * **Bilirubin:** The most clinically significant endogenous substrate for glucuronidation (forming Bilirubin Diglucuronide). * **Hippuric Acid:** Formed by the conjugation of **Glycine + Benzoic acid** (Commonly tested). * **Glutamine:** Conjugates with phenylacetate to form phenylacetylglutamine in humans.
Explanation: **Explanation:** The metabolism of **Bilirubin** is the classic physiological example of how the body handles an endogenous waste product using the same machinery designed for **xenobiotic detoxification** (biotransformation). **Why Bilirubin is the Correct Answer:** Xenobiotic metabolism typically involves two phases: **Phase I** (Functionalization, e.g., hydroxylation) and **Phase II** (Conjugation). Bilirubin, produced from heme degradation, is highly lipophilic and toxic. To be excreted, it must be made water-soluble. It undergoes **Phase II conjugation** in the liver, where the enzyme **UDP-glucuronosyltransferase (UGT1A1)** attaches glucuronic acid molecules to it, forming Bilirubin Diglucuronide. This process is identical to how many drugs and toxins are processed for biliary or renal excretion. **Analysis of Incorrect Options:** * **Myoglobin & Haemoglobin (A & D):** These are complex functional metalloproteins. They are not "metabolized" like small-molecule xenobiotics; rather, they are degraded into their constituent amino acids (recycled) and heme groups. * **Biliverdin (C):** This is an intermediate in heme catabolism. While it is a precursor to bilirubin, it is green, water-soluble, and does not require the complex conjugation machinery (Phase II) that characterizes xenobiotic-like detoxification. **High-Yield Clinical Pearls for NEET-PG:** * **Phase II Enzyme:** UDP-glucuronosyltransferase is the key enzyme. A deficiency leads to **Crigler-Najjar** or **Gilbert Syndrome**. * **Induction:** Phenobarbital can induce the UGT enzyme, which is why it is sometimes used to treat certain types of hyperbilirubinemia. * **Excretion:** Conjugated bilirubin is water-soluble and excreted in bile via the **MRP2 transporter** (defective in Dubin-Johnson Syndrome).
Explanation: **Explanation:** **1. Why Cytochrome P450 is correct:** The **Cytochrome P450 (CYP450)** system is a superfamily of heme-containing enzymes primarily located in the smooth endoplasmic reticulum of hepatocytes. It is the most critical component of **Phase I metabolism** (biotransformation). These enzymes function as **monooxygenases**, catalyzing the addition of a hydroxyl group (-OH) to hydrophobic drugs and xenobiotics. This process increases the water solubility of the compound, either preparing it for direct excretion or facilitating **Phase II conjugation** (e.g., glucuronidation). **2. Why the other options are incorrect:** * **Cytochrome (General):** This is a broad term for all heme-proteins involved in electron transport. While CYP450 is a cytochrome, the term is too non-specific as it includes proteins with entirely different functions. * **Cytochrome c:** This is a peripheral membrane protein found in the **inner mitochondrial membrane**. Its primary role is in the **Electron Transport Chain (ETC)**, shuttling electrons between Complex III and Complex IV to generate ATP. It is also a key marker for apoptosis. * **Cytochrome A:** This is a component of Cytochrome Oxidase (Complex IV) in the mitochondrial ETC. It is involved in cellular respiration, not drug detoxification. **3. High-Yield Clinical Pearls for NEET-PG:** * **Inducers vs. Inhibitors:** Knowledge of CYP450 inducers (e.g., Rifampicin, Phenytoin, Carbamazepine) and inhibitors (e.g., Ketoconazole, Erythromycin, Grapefruit juice) is frequently tested regarding drug-drug interactions. * **CYP3A4:** The most abundant isoform in the liver, responsible for metabolizing nearly 50% of all clinical drugs. * **Microsomal Enzyme System:** CYP450 is often referred to as the "microsomal" system because, upon cell fractionation, the endoplasmic reticulum forms vesicles called microsomes. * **Requirement:** The system requires **NADPH** and **Molecular Oxygen (O₂)** to function.
Explanation: **Explanation:** The metabolism of ethanol primarily occurs in the liver via two major oxidative steps. First, **Alcohol Dehydrogenase (ADH)** converts ethanol to acetaldehyde. Second, **Acetaldehyde Dehydrogenase (ALDH)** converts acetaldehyde to acetate. Both of these reactions require **NAD+** as a necessary co-factor, reducing it to **NADH**. In chronic alcoholism, the high rate of ethanol oxidation leads to a massive consumption of the cellular NAD+ pool. Because the body cannot regenerate NAD+ from NADH fast enough to keep up with heavy intake, the **NAD+/NADH ratio falls significantly**. Consequently, the availability of **NAD+** becomes the **rate-limiting factor** for alcohol clearance, rather than the enzyme concentration itself. **Analysis of Incorrect Options:** * **NADP & NADPH (Options A & C):** These are primarily involved in reductive biosynthesis (e.g., fatty acid synthesis) and the microsomal ethanol oxidizing system (MEOS). While MEOS uses NADPH and is induced in chronic alcoholics, it is a secondary pathway and not the primary rate-limiting component for bulk alcohol metabolism. * **FADH (Option D):** FADH2 is involved in the electron transport chain and certain TCA cycle reactions (like succinate dehydrogenase) but is not a co-factor for the primary ADH or ALDH enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic Consequences:** The high NADH:NAD+ ratio shifts the equilibrium of other reactions, leading to **lactic acidosis** (pyruvate → lactate), **fasting hypoglycemia** (inhibited gluconeogenesis), and **steatosis** (increased fatty acid synthesis). * **Zero-Order Kinetics:** Alcohol metabolism follows zero-order kinetics because the NAD+ co-factor is easily saturated. * **Disulfiram:** Inhibits ALDH, causing acetaldehyde accumulation, leading to the "hangover" symptoms used in aversion therapy.
Phase I Reactions: Cytochrome P450 System
Practice Questions
Phase II Conjugation Reactions
Practice Questions
Glutathione and Detoxification
Practice Questions
Drug Metabolism
Practice Questions
Metabolism of Xenobiotics
Practice Questions
Alcohol Metabolism
Practice Questions
Free Radical Generation and Antioxidant Defense
Practice Questions
Antioxidant Enzymes
Practice Questions
Detoxification of Heavy Metals
Practice Questions
Ammonia Detoxification Pathways
Practice Questions
Bilirubin Metabolism and Jaundice
Practice Questions
Biotransformation in Liver Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free